PALO ALTO, Calif.--(BUSINESS WIRE)--Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection. By ...
Leading life sciences investors ARCH Venture Partners, F-Prime Capital, and Primer Ventures fuel company's expansion into cell and gene therapy, oncology, and molecular diagnostics PALO ALTO, Calif.-- ...
Countable Labs has raised $26m to advance the development and commercialisation activities for its single-molecule polymerase chain reaction (PCR) technology. The California-based company’s financing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results